Геморрагический инфаркт головного мозга

Бесплатный доступ

Короткий адрес: https://sciup.org/140187692

IDR: 140187692

Список литературы Геморрагический инфаркт головного мозга

  • Ворлоу Ч.П., Денис М.С., Гейн Ж.В. и др. Инсульт. -СПб: Политехника, 1998. -629 с.
  • Инсульт/Под ред. Верещагина Н.В., Пирадова М.А., Суслиной З.А. -М.: Интермедика, 2002. -189 с.
  • Одинак M.M, Кузнецов А.Н., Ерофеев А.А., Шевченко Ю.Л. Кардиогенный и ангиогенный церебральный эмболический инсульт. -М.: ГЭОТАР-Медиа, 2006. -270 с.
  • Очерки ангионеврологии/Под ред. Суслиной З.А. -М.: Атмосфера, 2005. -359 с.
  • Шевченко Ю.Л., Одинак М.М., Михайленко А.А., Кузнецов А.Н. Кардиоэмболический инсульт. -СПб., 1997. -66 с.
  • Alexandrov A.V., Black S.E., Ehrlich L.E. et al. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke//Stroke. -1997. -Vol. 28. -P. 1198-1202.
  • Berger C., Fiorelli M., Steiner T. еt al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?//Stroke. -2001. -Vol. 32. -P. 1330-1339.
  • Bogousslavsky J. Anticoagulation and bleeding into embolic infarcts//Arch. Neurol. -1985. -Vol. 42. -P. 1033-1034.
  • Calandre L., Ortega J.F., Bermejo F. Anticoagulation and hemorrhagic infarction in cerebral embolism secondary to rheumatic heart disease//Arch. Neurol. -1984. -Vol. 41. -P. 1152-1154.
  • Cerebral Embolism Study Group. Timing of hemorrhagic transformation of cardioembolic stroke//Stroke. -1986. -Vol. 17. -P. 558.
  • Clark W.M., Madden K.P., Lyden P.D., Zivin J.A. Cerebral hemorrhagic risk of aspirin or heparin therapy with trombolytic treatment in rabbits//Stroke. -1991. -Vol. 22 -P. 872-876.
  • Combined intravenous and intra-arterial recanalization for acute ischemic stroke//Stroke. -2004. -Vol. 35. -P. 904-911.
  • del Zoppo G.J., Von Kummer R., Hamann G.F. Ischaemic damage of brain microvessels//J. Neurol. Neurosurg. Psychiatry. -1998. -Vol. 65. -P. 1-9.
  • Denny-Brown D., Meyer J.S. The cerebral collateral circulation//Neurology. -1957. -Vol. 7. -P. 567-579.
  • Derex L., Hermier M., Adeleine P. et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator//J. Neurol. Neurosurg. Psych. -2005. -Vol. 76. -P. 70-75.
  • Faris A.A. Hardin C.A., Poser C.M. Pathogenesis of hemorrhagic infarction of the brain//Arch. Neurol. -1963 -Vol. 9. -P. 468-472.
  • Fiorelli M., Bastianello S., Von Kummer R. et al. Hemorrhagic transformation within 36 hours of a cerebral infarct//Stroke. -1999. -Vol. 30. -P. 2280-2284.
  • Fisher C.M., Adams R.D. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction//J. Neuropathol. Exp. Neurol. -1951. -Vol. 10. -P. 92-93.
  • Globus J.H., Epstein J.A. Massive cerebral hemorrhage//J. Neuropathol. Exp. Neurol. -1953. -Vol. 12. -P. 107-131.
  • Hacke W., Albers G., Al-Rawi Y. et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)//Stroke. -2005. -Vol. 36. -P. 66-73.
  • Hacke W., Kaste M., Fieschi C. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke//Lancet. -1998. -Vol. 352. -P. 1245-1250.
  • Haley E.C., Lyden P.D., Johnston K.C. et al. A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke//Stroke. -2005. -Vol. 36. -P -236-258.
  • Hart R.G., Easton J.D. Hemorrhagic infarcts//Stroke. -1986. -Vol. 17. -P. 586-589.
  • Hebbrecht G., Maenhaut W., De Reuck J. Comparison of trace element alterations and water content in haemorrhagic and non-haemorrhagic cerebral infarcts//Cerebrovasc. Dis. -1994. -Vol. 4. -P. 412-416.
  • Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke//Stroke. -1997. -Vol. 28. -P. 2109-2118.
  • Kase C.S., Furlan A.J., Wechsler L.R. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke//Neurology. -2001. -Vol. 57. -P. 1603-1610.
  • Kerenyi L., Kardos L., Sza´sz J. et al. Factors influencing hemorrhagic ransformation in ischemic stroke: a clinicopathological comparison//Europ. J. of Neurol. -2006. -Vol. 13. -P. 1251-1255.
  • Khatri P., Wechsler L.R., Broderick J.P. Intracranial Hemorrhage Associated With Revascularization Therapies//Stroke. -2007. -Vol. 38. -P. 431-440.
  • Kidwell C.S., Alger J.R., Saver J.L. Evolving paradigms in neuroimaging of the ischemic penumbra//Stroke. -2004. -Vol. 35. -P. 2662-2665.
  • Kidwell C.S., Chalela J.A., Saver J.L. et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage//JAMA. -2004. -Vol. 292. -P. 1823-1830.
  • Kim E.Y., Na D.G., Kim S.S. et al. Prediction of hemorrhagic transformation in acute ischemic stroke//Am. J. Neuroradiol. -2005. -Vol. 26. -P. 1050-1055.
  • Larrue V., Von Kummer R., Del Zoppo G., Bluhmki E. Hemorrhagic transformation in acute ischemic stroke//Stroke. -1997. -Vol. 28. -P. 957-960.
  • Larrue V., von Kummer R., Mu¨ller A., Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)//Stroke. -2001. -Vol. 32. -P. 438-441.
  • Levy D.E., Brott T.G., Haley E.C. et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke//Stroke. -1994. -Vol. 25. -P. 291-297.
  • Lodder J., Krijne-Kubat B., Broekman j. Cerebral hemorrhagic infarction at autopsy//Stroke. -1986. -Vol. 17. -P. 626-629.
  • Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke//JAMA. -1998. -Vol. 279. -P. 1265-1272.
  • Lyden P.D., Zivin J.A. Hemorrhagic transformation after cerebral ischemia//Cerebrovasc. Brain Met. Rev. -1993. -Vol. 5. -P. 1-16.
  • Molina C.A, Montaner J., Abilleira S. et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke//Stroke. -2001. -Vol. 32. -P. 1079-1084.
  • Molina C.A., Alvarez-Sabin J., Montaner J. et al. Thrombolysis-related hemorrhagic infarction//Stroke. -2002. -Vol. 33. -P. 1551-1556.
  • Montaner J., Molina C.A., Monasterio J. et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke//Circulation. -2003. -Vol. 107. -P. 598-603
  • Ogata J., Yutani C., Imakita M. et al. Hemorrhagic infarction of the brain without a reopening of the occluded arteries in cardioembolic stroke//Stroke. -1989. -Vol. 20. -P. 876-883.
  • Ott B.R., Zamani A., Kleefield J., Funkenstein HH. The clinical spectrum of hemorrhagic infarction//Stroke. -1986. -Vol. 17. -P. 630-637.
  • Pessin M.S., Teal P.A., Caplan L.R. Hemorrhagic infarction: guilt by association//Am. J. Neuroradiol. -1991. -Vol. 12. -P. 1123-1126.
  • Pexman J.H., Barber P.A., Hill M.D. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke//Am. J. Neuroradiol. -2001. -Vol. 22. -P. 1534-1542.
  • Rha J., Saver J.L. The Impact of Recanalization on Ischemic Stroke Outcome//Stroke. -2007. -Vol. 38. -P. 967-973.
  • Rother J., Rosso C., Samson Y. et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke//Stroke. -2006. -Vol. 37. -P. 2463-2466.
  • Tanne D., Kasner S.E., Demchuk A.M. et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice//Circulation. -2002. -Vol. 105. -P. 1679-1685.
  • Tong D.C., Adami A., Moseley M.E. et al. Prediction of hemorrhagic transformation following acute stroke//Arch. Neurol. -2001. -Vol. 58. -P. -587-593.
  • Toni D., Fiorelli M., Bastianello S. et al. Hemorrhagic transformation of brain infarct//Neurology. -1996. Vol. -46. -P. 341-345.
  • Torvik A. The pathogenesis of watershed infarcts in the brain//Stroke. -1984. -Vol. 15. -P. 221-223.
  • Trouillas P., von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke/Stroke. -2006. -Vol. 37. -P. 554-560.
  • von Kummer R., Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke//Stroke. -1992. -Vol. 23. -P. 646-652.
  • Warach S., Latour L.L. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption/Stroke. -2004. -Vo. 35. -P. 2659-2661.
  • Wardlaw J.M., Dennis M.S., Lindley R.I. et al. Does early reperfusion of a cerebral infarct influence cerebral infarct swelling in the acute stage or the final clinical outcome?/Cerebrovasc. Dis. -1993. -Vol. 3. -P. -86-93.
  • Wolpert S., Bruckmann H., Greenlee R. et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogenactivator//AJNR. -1993. -Vol. 14. -P. 3-13.
Еще
Статья обзорная